Drugs in MeSH Category Leprostatic Agents
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emcure Pharms Ltd | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 204101-001 | Aug 18, 2014 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Epic Pharma | RIFAMPIN | rifampin | CAPSULE;ORAL | 064150-001 | May 28, 1997 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Nostrum Labs Inc | DAPSONE | dapsone | TABLET;ORAL | 203887-002 | May 6, 2016 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Torrent | DAPSONE | dapsone | GEL;TOPICAL | 214722-001 | Feb 10, 2022 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |